Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) - Total Liabilities
Based on the latest financial reports, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has total liabilities worth CN¥362.71 Million CNY (≈ $53.08 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zhejiang Cheng Yi Pharmaceutical Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Zhejiang Cheng Yi Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Zhejiang Cheng Yi Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Zhejiang Cheng Yi Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Cheng Yi Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hexagon Purus As
OL:HPUR
|
Norway | Nkr3.05 Billion |
|
Nepes Corporation
KQ:033640
|
Korea | ₩458.11 Billion |
|
BOKU INC. REG S DL-0001
F:B04
|
Germany | €347.79 Million |
|
Beijing Hanbang Technology Corp
SHE:300449
|
China | CN¥157.86 Million |
|
CoinShares International Ltd
ST:CS
|
Sweden | Skr5.77 Billion |
|
Hubei Yingtong Telecommunication Cable Co Ltd
SHE:002861
|
China | CN¥522.44 Million |
|
Posiflex Technology Inc
TW:8114
|
Taiwan | NT$6.51 Billion |
|
Zhewen Pictures Group Co Ltd
SHG:601599
|
China | CN¥1.99 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Zhejiang Cheng Yi Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 603811 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Cheng Yi Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual total liabilities of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥463.31 Million ≈ $67.80 Million |
-33.45% |
| 2023-12-31 | CN¥696.15 Million ≈ $101.87 Million |
+10.82% |
| 2022-12-31 | CN¥628.16 Million ≈ $91.92 Million |
+94.11% |
| 2021-12-31 | CN¥323.62 Million ≈ $47.36 Million |
+0.88% |
| 2020-12-31 | CN¥320.79 Million ≈ $46.94 Million |
+51.83% |
| 2019-12-31 | CN¥211.29 Million ≈ $30.92 Million |
+48.33% |
| 2018-12-31 | CN¥142.45 Million ≈ $20.84 Million |
+94.04% |
| 2017-12-31 | CN¥73.41 Million ≈ $10.74 Million |
-12.72% |
| 2016-12-31 | CN¥84.11 Million ≈ $12.31 Million |
-2.44% |
| 2015-12-31 | CN¥86.21 Million ≈ $12.62 Million |
+4.16% |
| 2014-12-31 | CN¥82.77 Million ≈ $12.11 Million |
-37.50% |
| 2013-12-31 | CN¥132.43 Million ≈ $19.38 Million |
-26.42% |
| 2012-12-31 | CN¥179.99 Million ≈ $26.34 Million |
-6.78% |
| 2011-12-31 | CN¥193.09 Million ≈ $28.25 Million |
-- |
About Zhejiang Cheng Yi Pharmaceutical Co Ltd
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co.,… Read more